Early Access

10-QPeriod: Q2 FY2017

CVS HEALTH Corp Quarterly Report for Q2 Ended Jun 30, 2017

Filed August 8, 2017For Securities:CVS

Summary

CVS Health Corporation's (CVS) 10-Q filing for the period ending June 29, 2017, reveals a mixed operational performance for the second quarter and first half of the year. While the company demonstrated revenue growth, driven by strong performance in its PBM and Retail Pharmacy segments, profitability faced pressures. Investors should note the increase in total revenues, indicating continued top-line expansion. However, a closer look at the income statement reveals that while revenue grew, the cost of sales and operating expenses also rose, impacting net income. The balance sheet reflects a solid financial position, but changes in working capital and debt levels should be monitored for their impact on liquidity and leverage. Operational highlights indicate robust prescription volume growth and a steady increase in same-store sales within the retail segment. The company's PBM services continue to be a significant driver of its business. Despite these strengths, management's discussion highlights the competitive landscape and evolving healthcare trends as key factors influencing results. Investors should pay attention to the company's strategies for managing costs, its outlook on market share, and any commentary regarding the integration of recent or potential future acquisitions, as these will be crucial for sustained profitable growth.

Financial Statements
Beta
Revenue$45.69B
Cost of Revenue$38.75B
Gross Profit$6.93B
Operating Expenses$4.81B
Operating Income$2.12B
Net Income$1.10B
EPS (Basic)$1.07
EPS (Diluted)$1.07
Shares Outstanding (Basic)1.02B
Shares Outstanding (Diluted)1.02B

Key Highlights

  • 1Total revenues increased compared to the prior year period, indicating top-line growth.
  • 2The Pharmacy Benefit Management (PBM) segment and Retail Pharmacy segment were key drivers of revenue.
  • 3Prescription volume continues to show positive growth, reflecting strong demand for pharmacy services.
  • 4Same-store sales in the retail segment experienced an increase, suggesting healthy consumer demand at the store level.
  • 5Operating income and net income showed fluctuations, warranting a deeper dive into expense management and profitability trends.
  • 6The company maintained a substantial cash flow from operations, supporting its financial flexibility.
  • 7Management discussed the competitive environment and ongoing healthcare industry changes as factors influencing performance.

Frequently Asked Questions